Protein Therapeutics Market Growth 2016-2020 - PowerPoint PPT Presentation

Loading...

PPT – Protein Therapeutics Market Growth 2016-2020 PowerPoint presentation | free to download - id: 7ed4ad-NmRmO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Protein Therapeutics Market Growth 2016-2020

Description:

Technavios market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market. – PowerPoint PPT presentation

Number of Views:19

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Protein Therapeutics Market Growth 2016-2020


1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Protein Therapeutics Market 2016-2020
Growth, Global Share, Industry Overview,
Analysis, Trends Opportunities and Forecast
2
Description
Report Overview
Market outlook of the protein therapeutics
market   Research analyst predicts the global
protein therapeutics market to grow steadily at a
CAGR of 8 during the forecast period. Increased
demand for and use of monoclonal antibodies is
expected to drive the growth of the protein
therapeutics market as it accounts for more than
half of the protein therapeutics market. The
monoclonal antibodies can be prepared specific to
any cell surface or extracellular target. These
antibodies are being used in radioimmunotherapy
and antibody-directed enzyme prodrug therapy.
Monoclonal antibodies are also used in the
formulation of various biopharmaceutical drugs
for the treatment of different diseases such as
cancer, rheumatoid arthritis, multiple sclerosis,
and UC.   Read more details at
http//www.bigmarketresearch.com/global-protein-th
erapeutics-2016-2020-market
3
Key Benefits
Summery
Product segmentation and analysis of the protein
therapeutics market   Monoclonal
antibodies Erythropoietin Insulin Human growth
hormone Interferons Blood clotting
factor G-CSF Follicle stimulating hormone The
monoclonal antibodies segment dominated the
market during 2015, with a market share of 55.
An increase in the prevalence of cancer and
autoimmune diseases, increase in research
activities, and increased technological
advancement in the development of next-generation
antibodies are the main factors fueling the
growth of this segment.
4
Key Benefits
Summery
Geographical segmentation and analysis of the
protein therapeutics market   Americas APAC EMEA T
he Americas accounted for 48 of the market share
during 2015 and is expected to grow at a CAGR of
7 during the forecast period. The promising
public health approaches by the government,
growing incidence, and an increase in regulatory
support for the development of protein
therapeutics are the primary drivers for the
market growth in this region.   Competitive
landscape and key vendors   The global protein
therapeutics market is highly fragmented due to
the presence of numerous small and large vendors.
The vendors in the market compete on the basis of
price, quality, and innovation. Competition among
the vendors has led an increased number of MA,
wherein smaller entities are being acquired by,
or are being merged with, major players.  
5
Key Audiences
The leading vendors in the market are
-   AbbVie Amgen F. Hoffmann-La Roche Johnson
Johnson Merck Novo Nordisk Other prominent
vendors in the market include Anhui Anke
Biotechnology, AstraZeneca, Baxter International,
Biocon, Biodel, Biogenomics, BioPartners,
Boehringer Ingelheim, Bristol-Myers Squibb,
Celltrion, Chugai Pharmaceutical, Diamyd Medical,
Diasome Pharmaceuticals, DiaVacs, Dynavax
Technologies, Eli Lilly, Ferring Pharmaceuticals,
Generex Biotechnology, GeneScience
Pharmaceuticals, Hualan Biological Engineering,
Intas Pharmaceuticals, Ipsen, JCR
Pharmaceuticals, Kyowa Hakko Kirin, Lexicon
Pharmaceuticals, LG Life Sciences, Macrogenics,
MannKind, Oramed Pharmaceuticals, Osiris
Therapeutics, Pfizer, Sandoz International,
Sanofi, Teva Pharmaceutical Industries, Thermalin
Diabetes, Tolerion, Wockhardt, and XOMA.
6
Key Audiences
Key questions answered in the report
include   What will the market size and the
growth rate be in 2020 What are the key factors
driving the global protein therapeutics
market What are the key market trends impacting
the growth of the protein therapeutics
market What are the challenges to market
growth Who are the key vendors in this market
space What are the market opportunities and
threats faced by the vendors in the global
protein therapeutics market Trending factors
influencing the market shares of the Americas,
APAC, and EMEA What are the key outcomes of the
five forces analysis of the protein therapeutics
market   Enquire about report http//www.bigmarke
tresearch.com/report-enquiry/363077
7
Get Full Information At http//www.bigmarketrese
arch.com/global-protein-therapeutics-2016-2020-mar
ket
About PowerShow.com